ScinoPharm has been selected by Clinical Data, Inc. to provide the manufacture of vilazodone hydrochloride API for Viibryd, a recently FDA-approved antidepressant. Viibryd is for the treatment of adults with major depressive disorder (MDD). The drug is different from other antidepressants in that it does not cause significant weight gain or interference with sexual function. “ScinoPharm is proud of the fruitful partnership with Clinical Data by being its sole API supplier of vilazodone ...